From the Food and Drug Administration.
Schwetz
Bernard A
BA
D000279:Administration, Cutaneous; D000328:Adult; D002648:Child; D003271:Contraceptive Agents, Female; D003879:Dermatologic Agents / Q000009:adverse effects*; D004997:Ethinyl Estradiol; D005260:Female; D006344:Heart Septal Defects, Atrial / Q000601:surgery*; D006345:Heart Septal Defects, Ventricular / Q000601:surgery*; D006801:Humans; D015474:Isotretinoin / Q000009:adverse effects*; D016912:Levonorgestrel / Q000031:analogs & derivatives; D008297:Male; D019736:Prostheses and Implants; D012308:Risk Management; D014481:United States; D014486:United States Food and Drug Administration
D003271:Contraceptive Agents, Female; D003879:Dermatologic Agents; D004997:Ethinyl Estradiol; D016912:Levonorgestrel; D015474:Isotretinoin